Evidence map›Paper›PMID 33246893›Full record

ArticleEpilepsy & behavior : E&B2021

Neurologist prescribing versus psychiatry referral: Examining patient preferences for anxiety and depression management in a symptomatic epilepsy clinic sample.

Heidi M Munger Clary, Rachel D Croxton, Beverly M Snively, Gretchen A Brenes, James Lovato, Fatemeh Sadeghifar, James Kimball, Cormac O'Donovan, Kelly Conner, Esther Kim and 2 more

Open access · greenAbstract read
In one paragraph

Article in Epilepsy & behavior : E&B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Epilepsy & behavior reports · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Heidi M Munger ClaryDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: hmungerc@wakehealth.edu.
Rachel D CroxtonDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: croxrd13@alumni.wfu.edu.
Beverly M SnivelyDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: bmellen@wakehealth.edu.
Gretchen A BrenesDepartment of Internal Medicine, Section on Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: gbrenes@wakehealth.edu.
James LovatoDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: jlovato@wakehealth.edu.
Fatemeh SadeghifarDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: fsadeghi@wakehealth.edu.
James KimballDepartment of Psychiatry, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: jkimball@wakehealth.edu.
Cormac O'DonovanDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: odonovan@wakehealth.edu.
Kelly ConnerDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: kconner@wakehealth.edu.
Esther KimDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: EKKim@mednet.ucla.edu.
Jonathan AllanDepartment of Psychiatry, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: drallan@happierliving.com.
Pamela DuncanDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA. Electronic address: pduncan@wakehealth.edu.
Wake Forest University · US

Funding

Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Wake Forest Clinical and Translational Science AwardKL2TR001421 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MILLER, DAVID P · 2015 to 2023
$5.8M
Wake Forest NeuroNext Clinical Site (WAKENN)U24NS107197 · NINDS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Mustapha Ahmad Ezzeddine, Roy Ervin Strowd · 2018 to 2026
$3.2M
Enhancing Scientific Inquiry in Clinical Neurosciences Through Methodology TrainiR25NS088248 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COFFEY, CHRISTOPHER S., GUTMANN, LAURIE · 2014 to 2018
$2.3M
Affordability and Efficiency for COMprehensive Post-Acute Stroke Services (COMPASS)R01HS025723 · AHRQ · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSHNELL, CHERYL D, TROGDON, JUSTIN · 2018 to 2021
$1.6M
AHRQ HHS R01 HS025723NCATS NIH HHS KL2 TR001421NCATS NIH HHS UL1 TR001420NINDS NIH HHS R25 NS088248NINDS NIH HHS U24 NS107197
6 · The paper itself

Abstract

objectiveAnxiety and depression symptoms in epilepsy are common, impactful and under-recognized and undertreated. While prior survey data suggests equipoise among epileptologists for managing anxiety and/or depression via prescribing in the epilepsy clinic versus psychiatry referral, patient preferences are unknown and should potentially influence practice habits among epileptologists. Thus, the primary objective of this study was to determine patient preference for anxiety and/or depression prescribing by neurologists versus psychiatry referral among an adult epilepsy clinic sample of symptomatic patients.

methodsManagement preferences for anxiety and/or depression were surveyed in an adult tertiary care epilepsy clinic. Individuals who screened positive for anxiety and/or depression symptoms on validated instruments during a routine care-embedded learning health system study were recruited. Demographics, social variables, psychiatric treatment history, and treatment priorities and preferences were surveyed. Preference was defined as a slightly greater than 2:1 ratio in favor neurology prescribing or psychiatry referral. The study was powered to assess this primary objective using a two-sample binomial test. Multinomial logistic regression examined an a priori multivariable model of treatment preference (secondary objective).

resultsThe study sample included N = 63 symptomatic adults, with 64% women and mean age 42.2 years. Most reported past or current treatment for anxiety and/or depression, and treatment for these symptoms was a high or moderate priority among 65.1% of the sample. Neurologist prescribing was preferred in 83.0% (nearly 5:1) over psychiatry referral among those who chose neurology or psychiatry (as opposed to neither of the two; p < 0.001, 95% CI 0.702-0.919). Overall, 69.8% of the total study sample preferred neurology prescribing. Multivariable modeling indicated preference for neither management option (compared with neurologist prescribing) was associated with low overall treatment prioritization and having never received neurologist medication management. None of the factors examined in the a priori multivariable model were associated with selecting psychiatry referral (compared to neurologist prescribing).

conclusionIn this sample, most patients indicated a preference for neurologists to prescribe for anxiety or depression symptoms in the epilepsy clinic. Care models involving neurologist prescribing for anxiety and depression symptoms merit further investigation and potential adoption in clinical practice.

Indexed as

EpilepsyPsychiatryAdultAnxietyDepressionFemaleHumansMaleNeurologistsPatient PreferenceReferral and ConsultationAnxietyDepressionEpilepsyNeurologistPatient treatment preferencesPsychiatrist

Identifiers

PMID33246893
PMCPMC7855561
OpenAlexW3108614674

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.